Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Advances in MS Management: Current and Future Directions
Advances in MS Management: Current and Future Directions
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
Exploring Metabolomics in Multiple Sclerosis
Exploring Metabolomics in Multiple Sclerosis
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
Multiple Sclerosis Explained: Understanding Its Epidemiology
Multiple Sclerosis Explained: Understanding Its Epidemiology
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
Genetics and Schizophrenia: Key Ethical Considerations
Genetics and Schizophrenia: Key Ethical Considerations
